Graves' Disease & Thyroid Foundation

Patients with thyroid eye disease often rely on OTC eye drops for symptom relief, but it seems like there's a new recall in the news every other month. If you have concerns about what's in your medicine cabinet, check out eyedropsafety.org, a project of the @dry_eye_fdn.

Science can move "gradually, then suddenly"! Just days after we attended the ASOPRS Fall Symposium - which included talks on the SatraGO-1 and SatraGO-2 trials - the FDA has approved Enspryng as the first subcutaneous treatment for thyroid eye disease. optometryadvisor.com/news/enspryng-…

If you are attending the #ASOPRS Fall Scientific Symposium in New Orleans, stop by booth #103 in the exhibit hall and say hello!

USA-based Graves' patients: the GDATF wants to hear from you! As a final step before sharing our survey results, we'll be hosting three focus groups in October, and we'd be honored if you would participate! More info here: gdatf.org/gdatf-focus-gr…

THANK YOU to the 400+ patients who took the time to complete our Graves' survey. If you are curious how we share survey data, check out this page from our website with highlights from our 2022 TED survey. gdatf.org/resources/ted-…